DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
Aktie
APPLIED GENETIC TECHNOL. CO
A110V2 / US03820J1007
0,39
USD
+1,23
%
News
Syngenta Group reports $32.2 billion sales and $4.6 billion EBITDA in 2023
News
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
News
EQS-News: Heidelberg Pharma präsentiert erste Wirksamkeitsdaten zu HDP-101 und Daten der proprietären ADC-Technologieplattform auf der AACR-Tagung 2024
News
Syngenta Group expands collaborations for more innovative scientific and technological solutions in agriculture
News
Media Release Syngenta Group Reports 9M 2023 Results
News
Syngenta Group recognized as top agriculture employer for the seventh consecutive year in 2023 by Science magazine survey; ranked No. 5 overall
News
ADM and Syngenta Group Sign MoU to Support Low-Carbon Next-Generation Oilseeds and Improved Varieties to Meet Growing Demand for Biofuels and Other Products
News
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
News
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
News
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Aktie
Genetic Technologies Ltd Shs
A3E2MZ / US37185R4065
2,32
USD
-4,92
%
News
Syngenta Group reports $32.2 billion sales and $4.6 billion EBITDA in 2023
News
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
News
EQS-News: Heidelberg Pharma präsentiert erste Wirksamkeitsdaten zu HDP-101 und Daten der proprietären ADC-Technologieplattform auf der AACR-Tagung 2024
News
Syngenta Group expands collaborations for more innovative scientific and technological solutions in agriculture
News
Media Release Syngenta Group Reports 9M 2023 Results
News
Syngenta Group recognized as top agriculture employer for the seventh consecutive year in 2023 by Science magazine survey; ranked No. 5 overall
News
ADM and Syngenta Group Sign MoU to Support Low-Carbon Next-Generation Oilseeds and Improved Varieties to Meet Growing Demand for Biofuels and Other Products
News
Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics
News
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health
News
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East
Aktie
APPLIED GENETIC TECHNOL. CO
A110V2 / US03820J1007
0,39
USD
+1,23
%
Aktie
Genetic Technologies Ltd Shs
A3E2MZ / US37185R4065
2,32
USD
-4,92
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter